Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study

PURPOSE: We conducted a randomized phase III trial to determine whether adjuvant chemotherapy improves survival in women with uterine leiomyosarcoma. METHODS: Women with uterus-confined, high-grade leiomyosarcoma who were confirmed disease free by imaging were randomly assigned to four cycles of gem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Hensley, Martee L., Enserro, Danielle, Hatcher, Helen, Ottevanger, Petronella B., Krarup-Hansen, Anders, Blay, Jean-Yves, Fisher, Cyril, Moxley, Katherine M., Lele, Shashikant B., Lea, Jayanthi S., Tewari, Krishnansu S., Thaker, Premal H., Zivanovic, Oliver, O’Malley, David M., Robison, Katina, Miller, David S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2018
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6241678/
https://ncbi.nlm.nih.gov/pubmed/30289732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00454
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados